Pharma Manufacturers & Providers - HARE - HealthCare Analyst Report Romania

Home PharmaPharma Manufacturers & Providers

30-12-2013
MoH: National Health Strategy published

23-12-2013
Reshuffling Public Healthcare - the National Health Programs

23-12-2013
Reshuffling Public Healthcare - the Medical Packages

19-12-2013
IQWiG maintains the ruling "considerable added benefit" on vemurafenib (Zelboraf, Roche) in genetically specific advanced melanoma

19-12-2013
European and US drug regulators to start joint inspections regarding generic registrations

19-12-2013
GlaxoSmithKline (GSK) to initiate historical changes in its relationship with healthcare professionals and in sales employee compensation

18-12-2013
First-ever extensive survey on pediatric cancer reveals significant unmet need

17-12-2013
NHIH: Amendment of ePrescription template may affect market players

17-12-2013
Multiple myeloma at therapeutic turning point due to Revlimid (lenalidomide, Celgene)?

16-12-2013
Family physicians protest against financial penalties related to reimbursed prescriptions

12-12-2013
Health inequalities in the EU - highlights from the final report of December 2013

11-12-2013
Medical press in France - HAS reflection on quality criteria and good practice

10-12-2013
MoH: Draft Canamed published

09-12-2013
HAS updates guidelines on the administration of platelet aggregation inhibitors

09-12-2013
Sanofi's Aubagio (teriflunomide) receives good news from NICE

06-12-2013
NICE's Appraisal Committee minded not to recommend Genzyme / Sanofi's Lemtrada (alemtuzumab) in multiple sclerosis

06-12-2013
EU-wide stroke prevention campaign catalyzed by pharma industry

05-12-2013
IQWiG does not confirm added benefit of saxagliptin (Onglyza) as monotherapy in diabetes type 2

04-12-2013
MoH: Additional HTA files released

03-12-2013
Ministry of Health amends the Program for early emergency treatment of critical patients with myocardial infarction (AP-IMA)

02-12-2013
Minister of Health statements regarding current developments in two hospitals

29-11-2013
Safety review of novel oral anticoagulants (NACO) in France - good news for manufacturers, patients and healthcare professionals

27-11-2013
Novartis' Lucentis (ranibizumab) receives final NICE positive guidance for specific vascular condition associated with pathological myopia

27-11-2013
Ribavirin-peginterferon alpha combination endorsed by NICE for chronic hepatitis C in children and young people

26-11-2013
CHMP and PRAC positive recommendations on combined hormonal contraceptives (CHC) concur

« Previous 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 Next »

Advanced Search

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company